15-7-4　ⓔ文献

  1. DeLellis RA, Lloyd RV, et al eds: Pathology and Genetics of Tumours of Endocrine Organs. IARC Press, World Health Organization classification of Tumours, 2004; 8.

  2. Lloyd RV, Osamura RY, et al eds: WHO Classification of Tumours of Endocrine Organs: WHO Classification of Tumours, 4th ed, Vol 10, IARC, 2017; 10.

  3. Burnichon N, Rohmer V, et al: The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab, 2009; 94: 2817–2827.

  4. Neumann HP, Bausch B, et al: Germ–line mutations in nonsyndromic pheochromocytoma. N Engl J Med, 2002; 346: 1459–1466.

  5. Opocher G, Schiavi F: Genetics of pheochromocytomas and paragangliomas. Best Pract Res Clin Endocrinol Metab, 2010; 24: 943–956.

  6. Anderson Jr GH, Blakeman N, et al: The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens, 1994; 12: 609–615.

  7. 名和田　新：副腎ホルモン産生異常症の全国疫学調査．「厚生省特定疾患内分泌系疾患調査研究班 (班長　名和田　新) 平成10年度研究報告書」，1999; 11.

  8. White PC: Disorder of adrenal glands. Nelson Textbook of Pediatrics, 18th ed ( Kleigman RM, Behrman RE, et al eds), Saunders, 2007; 2372–2373.

  9. 成瀬光栄: 厚生労働省難治性疾患克服研究事業「褐色細胞腫の実態調査と診療指針の作成研究班」報告書.

  10. Thompson LD: Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol, 2002; 26: 551–566.

  11. Kimura N, Watanabe T, et al: Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra–adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol, 2005; 16: 23–32.

  12. Eisenhofer G, Goldstein DS, et al: Biochemical diagnosis of pheochromocytoma: how to distinguish true–from false–positive test results. J Clin Endocrinol Metab, 2003; 88: 2656–2666.

  13. Pussard E, Chaouch A, et al: Radioimmunoassay of free plasma metanephrines for the diagnosis of catecholamine–producing tumors. Clin Chem Lab Med, 2014; 52: 437–444.

  14. 日本内分泌学会「悪性褐色細胞腫の実態調査と診療指針の作成」委員会編：褐色細胞腫・パラガングリオーマ診療ガイドライン2018, 診断と治療社，2018.

  15. Young WF, Maddox D, et al: Spells: In search of cause. Mayo Clin Proc, 1995; 70; 757–765.

  16. Eisenhofer G, Sharabi Y, et al: Unexplained symptomatic paroxysmal hypertension in pseudopheochromocytoma: a stress response disorder? Ann N Y Acad Sci, 2008; 1148: 469–478.

  17. Naruse M, Satoh F, et al: Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi–center trial in Japan. Endocr J, 2018; 65: 359–371.